Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.

@article{Singh2015PerformanceCO,
  title={Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.},
  author={N Heramani Singh and Drew J. Winston and Ajit P Limaye and Shawn Pelletier and Nasia Safdar and Michele Ileana Morris and Katherine Meneses and Ronald W Busuttil and Marilyn M. Wagener and Laurence Joseph Wheat},
  journal={Transplantation},
  year={2015},
  volume={99 12},
  pages={2543-50}
}
BACKGROUND The utility of Aspergillus galactomannan (GM) and β-D-glucan (BG) in liver transplant recipients remains uncertain. METHODS As part of a randomized, double-blind trial of antifungal prophylaxis in liver transplant recipients at risk for invasive fungal infections (IFIs), GM and BG were assessed in 199 patients at baseline (enrollment) and weekly thereafter for the duration of study drug. Receiver operating characteristic (ROC) analysis was used to evaluate the accuracy of these for… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS